Search
for

    Learn

    5 / 801 results

      learn Hydrocortisone

      a synthetic cortisol used for anti-inflammatory effects

      learn Fluridil

      a topical anti-androgen with less systemic involvement

      learn Finasteride

      Frontline, gold standard treatment for combatting androgenic alopecia

    Research

    5 / 1000+ results

    Community Join

    5 / 720 results
      Should i be worried dut 6 months

      community Should i be worried dut 6 months

      in General  122 upvotes 3 months ago
      The user has been using finasteride and minoxidil, then switched to dutasteride and minoxidil for six months without significant results, noticing thinning after increasing creatine dosage. They plan to consult a dermatologist to explore potential causes beyond androgenetic alopecia.
      If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      community If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      in Research  830 upvotes 1 year ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community Anyone else realize how many younger guys are balding?

      in Chat  262 upvotes 1 year ago
      Many younger men are experiencing hair loss due to genetics, diet, stress, and lifestyle changes. Treatments like finasteride and minoxidil are mentioned, with some users noting improvements.

      community HLT Megathread on HMI-115 (key takeaways in comments)

      in Research/Science  39 upvotes 3 years ago
      HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.